GlaxoSmithKline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company's shares is closed from Wednesday, 1st July, 2020 and shall reopen on Monday, 3rd August, 2020 after the approval and declaration of Un-audited financial results for the first quarter ended 30th June, 2020 by the Board of Directors at its meeting scheduled to be held on 29th July, 2020.
The above information is a part of company’s filings submitted to BSE.
